Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?

A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restri...

Full description

Bibliographic Details
Main Authors:	Jack, William, Lanjouw, Jean O.
Format:	Journal Article
Language:	English en_US
Published:	Published by Oxford University Press on behalf of the World Bank 2014
Subjects:	ADVERTISING ARBITRAGE BENCHMARK CONSUMER DEMAND CONSUMER SURPLUS CONSUMERS COST INCREASES COST OF CAPITAL COUNTRY MARKETS CUSTOMS DAMAGES DEMAND ELASTICITY DEVELOPING ECONOMIES DEVELOPING ECONOMY DEVELOPMENT ASSISTANCE DIFFERENTIAL PRICING E-MAIL E-MAIL ADDRESS ECONOMIC COOPERATION ECONOMIC LAW ECONOMIC RENTS ELASTICITY ELASTICITY OF DEMAND FAIR FIXED COSTS FORMAL ANALYSES FREE MARKET INCENTIVE EFFECTS INCOME INCOME LEVELS INCOME TAX INCOMES INCREASING RETURNS INCREASING RETURNS TO SCALE INNOVATION INNOVATION POLICY INNOVATIONS INSTITUTION INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY RIGHTS INVENTION LEGAL ISSUES LICENSE LICENSES MACROECONOMICS MANUFACTURING MARGINAL COST MARGINAL COST OF PRODUCTION MARGINAL COST PRICING MARGINAL COSTS MARGINAL REVENUE MARGINAL UTILITY MARKETING MONOPOLY MONOPOLY PRICE MONOPOLY PRICES NEW PRODUCTS PATENTS POSTAL SERVICE POSTAL SERVICES PRICE CEILINGS PRICE CONTROL PRICE CONTROLS PRICE DISCRIMINATION PRICE INCREASE PRICE LEVELS PRICE REGULATION PRICE STRUCTURE PRICE STRUCTURES PRICING MODEL PRICING POLICIES PROCUREMENT PRODUCTIVITY PROFIT MARGIN PROPERTY RIGHTS PUBLIC FINANCE PUBLIC POLICY R&AMP;D RAMSEY PRICE RAMSEY PRICES REGULATORS REGULATORY FRAMEWORK RESEARCH INVESTMENT RESULT RESULTS RETURNS TO SCALE SALE SALES SALES ARRANGEMENTS SAVINGS SENIOR CITIZEN SOCIAL COST SOCIAL COSTS SOCIAL VALUE SUPPLIERS TARGETS TAX TAX CREDITS TAX RATES TAX STRUCTURE TAX SYSTEM TAXATION USES UTILITY FUNCTION VOTERS WORLD TRADE WORLD TRADE ORGANIZATION WTO
Online Access:	http://documents.worldbank.org/curated/en/2005/01/17747581/financing-pharmaceutical-innovation-much-poor-countries-contribute http://hdl.handle.net/10986/16481

id	okr-10986-16481
recordtype	oai_dc
spelling	okr-10986-164812021-04-23T14:03:29Z Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute? Jack, William Lanjouw, Jean O. ADVERTISING ARBITRAGE BENCHMARK CONSUMER DEMAND CONSUMER SURPLUS CONSUMERS COST INCREASES COST OF CAPITAL COUNTRY MARKETS CUSTOMS DAMAGES DEMAND ELASTICITY DEVELOPING ECONOMIES DEVELOPING ECONOMY DEVELOPMENT ASSISTANCE DIFFERENTIAL PRICING E-MAIL E-MAIL ADDRESS ECONOMIC COOPERATION ECONOMIC LAW ECONOMIC RENTS ELASTICITY ELASTICITY OF DEMAND FAIR FIXED COSTS FORMAL ANALYSES FREE MARKET INCENTIVE EFFECTS INCOME INCOME LEVELS INCOME TAX INCOMES INCREASING RETURNS INCREASING RETURNS TO SCALE INNOVATION INNOVATION POLICY INNOVATIONS INSTITUTION INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY RIGHTS INVENTION LEGAL ISSUES LICENSE LICENSES MACROECONOMICS MANUFACTURING MARGINAL COST MARGINAL COST OF PRODUCTION MARGINAL COST PRICING MARGINAL COSTS MARGINAL REVENUE MARGINAL UTILITY MARKETING MONOPOLY MONOPOLY PRICE MONOPOLY PRICES NEW PRODUCTS PATENTS POSTAL SERVICE POSTAL SERVICES PRICE CEILINGS PRICE CONTROL PRICE CONTROLS PRICE DISCRIMINATION PRICE INCREASE PRICE LEVELS PRICE REGULATION PRICE STRUCTURE PRICE STRUCTURES PRICING MODEL PRICING POLICIES PROCUREMENT PRODUCTIVITY PROFIT MARGIN PROPERTY RIGHTS PUBLIC FINANCE PUBLIC POLICY R&AMP;D RAMSEY PRICE RAMSEY PRICES REGULATORS REGULATORY FRAMEWORK RESEARCH INVESTMENT RESULT RESULTS RETURNS TO SCALE SALE SALES SALES ARRANGEMENTS SAVINGS SENIOR CITIZEN SOCIAL COST SOCIAL COSTS SOCIAL VALUE SUPPLIERS TARGETS TAX TAX CREDITS TAX RATES TAX STRUCTURE TAX SYSTEM TAXATION USES UTILITY FUNCTION VOTERS WORLD TRADE WORLD TRADE ORGANIZATION WTO A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restrictions implied in the standard use of Ramsey pricing. Under the more general model, poor countries should not necessarily cover even their own marginal costs, and the pricing structure is not related to that which will be chosen by a monopolist in a simple way. This framework is then used to examine ongoing debates regarding the international patent system as embodied in the world trade organization's agreement on trade-related aspects of intellectual property rights. 2014-01-03T20:55:55Z 2014-01-03T20:55:55Z 2005-01 Journal Article http://documents.worldbank.org/curated/en/2005/01/17747581/financing-pharmaceutical-innovation-much-poor-countries-contribute World Bank Economic Review doi:10.1093/wber/lhi005 http://hdl.handle.net/10986/16481 English en_US CC BY-NC-ND 3.0 IGO http://creativecommons.org/licenses/by-nc-nd/3.0/igo World Bank Published by Oxford University Press on behalf of the World Bank Publications & Research :: Journal Article Publications & Research :: Journal Article
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English en_US
topic	ADVERTISING ARBITRAGE BENCHMARK CONSUMER DEMAND CONSUMER SURPLUS CONSUMERS COST INCREASES COST OF CAPITAL COUNTRY MARKETS CUSTOMS DAMAGES DEMAND ELASTICITY DEVELOPING ECONOMIES DEVELOPING ECONOMY DEVELOPMENT ASSISTANCE DIFFERENTIAL PRICING E-MAIL E-MAIL ADDRESS ECONOMIC COOPERATION ECONOMIC LAW ECONOMIC RENTS ELASTICITY ELASTICITY OF DEMAND FAIR FIXED COSTS FORMAL ANALYSES FREE MARKET INCENTIVE EFFECTS INCOME INCOME LEVELS INCOME TAX INCOMES INCREASING RETURNS INCREASING RETURNS TO SCALE INNOVATION INNOVATION POLICY INNOVATIONS INSTITUTION INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY RIGHTS INVENTION LEGAL ISSUES LICENSE LICENSES MACROECONOMICS MANUFACTURING MARGINAL COST MARGINAL COST OF PRODUCTION MARGINAL COST PRICING MARGINAL COSTS MARGINAL REVENUE MARGINAL UTILITY MARKETING MONOPOLY MONOPOLY PRICE MONOPOLY PRICES NEW PRODUCTS PATENTS POSTAL SERVICE POSTAL SERVICES PRICE CEILINGS PRICE CONTROL PRICE CONTROLS PRICE DISCRIMINATION PRICE INCREASE PRICE LEVELS PRICE REGULATION PRICE STRUCTURE PRICE STRUCTURES PRICING MODEL PRICING POLICIES PROCUREMENT PRODUCTIVITY PROFIT MARGIN PROPERTY RIGHTS PUBLIC FINANCE PUBLIC POLICY R&AMP;D RAMSEY PRICE RAMSEY PRICES REGULATORS REGULATORY FRAMEWORK RESEARCH INVESTMENT RESULT RESULTS RETURNS TO SCALE SALE SALES SALES ARRANGEMENTS SAVINGS SENIOR CITIZEN SOCIAL COST SOCIAL COSTS SOCIAL VALUE SUPPLIERS TARGETS TAX TAX CREDITS TAX RATES TAX STRUCTURE TAX SYSTEM TAXATION USES UTILITY FUNCTION VOTERS WORLD TRADE WORLD TRADE ORGANIZATION WTO
spellingShingle	ADVERTISING ARBITRAGE BENCHMARK CONSUMER DEMAND CONSUMER SURPLUS CONSUMERS COST INCREASES COST OF CAPITAL COUNTRY MARKETS CUSTOMS DAMAGES DEMAND ELASTICITY DEVELOPING ECONOMIES DEVELOPING ECONOMY DEVELOPMENT ASSISTANCE DIFFERENTIAL PRICING E-MAIL E-MAIL ADDRESS ECONOMIC COOPERATION ECONOMIC LAW ECONOMIC RENTS ELASTICITY ELASTICITY OF DEMAND FAIR FIXED COSTS FORMAL ANALYSES FREE MARKET INCENTIVE EFFECTS INCOME INCOME LEVELS INCOME TAX INCOMES INCREASING RETURNS INCREASING RETURNS TO SCALE INNOVATION INNOVATION POLICY INNOVATIONS INSTITUTION INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY RIGHTS INVENTION LEGAL ISSUES LICENSE LICENSES MACROECONOMICS MANUFACTURING MARGINAL COST MARGINAL COST OF PRODUCTION MARGINAL COST PRICING MARGINAL COSTS MARGINAL REVENUE MARGINAL UTILITY MARKETING MONOPOLY MONOPOLY PRICE MONOPOLY PRICES NEW PRODUCTS PATENTS POSTAL SERVICE POSTAL SERVICES PRICE CEILINGS PRICE CONTROL PRICE CONTROLS PRICE DISCRIMINATION PRICE INCREASE PRICE LEVELS PRICE REGULATION PRICE STRUCTURE PRICE STRUCTURES PRICING MODEL PRICING POLICIES PROCUREMENT PRODUCTIVITY PROFIT MARGIN PROPERTY RIGHTS PUBLIC FINANCE PUBLIC POLICY R&AMP;D RAMSEY PRICE RAMSEY PRICES REGULATORS REGULATORY FRAMEWORK RESEARCH INVESTMENT RESULT RESULTS RETURNS TO SCALE SALE SALES SALES ARRANGEMENTS SAVINGS SENIOR CITIZEN SOCIAL COST SOCIAL COSTS SOCIAL VALUE SUPPLIERS TARGETS TAX TAX CREDITS TAX RATES TAX STRUCTURE TAX SYSTEM TAXATION USES UTILITY FUNCTION VOTERS WORLD TRADE WORLD TRADE ORGANIZATION WTO Jack, William Lanjouw, Jean O. Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
description	A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restrictions implied in the standard use of Ramsey pricing. Under the more general model, poor countries should not necessarily cover even their own marginal costs, and the pricing structure is not related to that which will be chosen by a monopolist in a simple way. This framework is then used to examine ongoing debates regarding the international patent system as embodied in the world trade organization's agreement on trade-related aspects of intellectual property rights.
format	Journal Article
author	Jack, William Lanjouw, Jean O.
author_facet	Jack, William Lanjouw, Jean O.
author_sort	Jack, William
title	Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
title_short	Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
title_full	Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
title_fullStr	Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
title_full_unstemmed	Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
title_sort	financing pharmaceutical innovation : how much should poor countries contribute?
publisher	Published by Oxford University Press on behalf of the World Bank
publishDate	2014
url	http://documents.worldbank.org/curated/en/2005/01/17747581/financing-pharmaceutical-innovation-much-poor-countries-contribute http://hdl.handle.net/10986/16481
_version_	1764433346706800640

Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?

Similar Items